-
公开(公告)号:EP1688418A3
公开(公告)日:2008-05-14
申请号:EP06004401.3
申请日:2002-11-13
发明人: Luly, Jay R. , Nakasato, Yoshisuke , Ohshima, Etsuo , Harriman, Geraldine C. B. , Carson, Kenneth G. , Ghosh, Shomir , Elder, Amy M. , Mattia, Karen M.
IPC分类号: C07D491/04 , C07D497/04 , C07D223/20 , C07D313/12 , C07D337/12 , A61P1/00 , A61K31/4353 , A61K31/55 , C07D313/00 , C07D221/00 , C07D471/04 , C07D223/00 , C07D519/00 , C07D491/00 , C07D513/04 , C07D337/00 , C07D451/00
CPC分类号: C07D491/04 , C07D211/46
摘要: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.
-
公开(公告)号:EP1688418A2
公开(公告)日:2006-08-09
申请号:EP06004401.3
申请日:2002-11-13
发明人: Luly, Jay R. , Nakasato, Yoshisuke , Ohshima, Etsuo , Harriman, Geraldine C. B. , Carson, Kenneth G. , Ghosh, Shomir , Elder, Amy M. , Mattia, Karen M.
IPC分类号: C07D491/04 , C07D497/04 , C07D223/20 , C07D313/12 , C07D337/12 , A61P1/00 , A61K31/4353 , A61K31/55
CPC分类号: C07D491/04 , C07D211/46
摘要: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.
-
3.
公开(公告)号:EP0549352A2
公开(公告)日:1993-06-30
申请号:EP92311777.4
申请日:1992-12-24
发明人: Ohshima, Etsuo , Kanai, Fumihiko , Sato, Hideyuki , Obase, Hiroyuki , Kumazawa, Toshiaki , Takahara, Shiho , Ohno, Tetsuji , Ishikawa, Tomoko , Yamada, Koji
IPC分类号: C07D471/04 , A61K31/435 , A61K31/41 , A61K31/55 , A61K31/54 , C07D405/06 , C07D519/00 , C07D405/14 , C07D403/14 , C07D403/06 , C07D401/12
CPC分类号: C07D249/08 , C07D231/12 , C07D233/56 , C07D403/06 , C07D403/12 , C07D403/14 , C07D405/06 , C07D471/04
摘要: Novel tricyclic compounds and salts are disclosed useful as AII receptor antagonists. These are compounds of the formula I and their salts:
R1 represents hudrogen, halogen or C 1 -C 6 alkyl;
A represents cyano, carboxyl, tetrazolyl, cyano-substituted phenyl, carboxyl-substituted phenyl or tetrazolyl-substituted phenyl;
V represents -(CH 2 ) m -, where m is 0,1 or 2;
W represents a group of the formula α, β, γ or δ
where α is:
where R 2 , R 3 and R 4 are each hydrogen, halogen, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, halogenated C 1 -C 6 alkyl, hydroxy, C 1 -C 6 alkoxy, amino, C 1 -C 6 alkylamino, carboxyl or C 1 -C 6 alkoxycarbonyl; and Q 1 -Q 2 -Q 3 -Q 4 represents N=CH-CH=CH, CH=CH-CH=CH or CH 2 -CH 2 -CH 2 -CH 2 :
β is:
wherein R 2 , R 3 and R 4 are as defined above:
γ is:
where R 5 and R 6 each represent hydrogen, C 1 -C 6 alkyl or C 3 -C 6 cycloalkyl, and R 7 represents carboxyl, C 1 -C 6 alkoxycarbonyl, carbamoyl or hydroxymethyl; and
δ is:
where R 8 and R 9 each represent hydrogen or C 1 -C 6 alkyl, and Q represents N or CH;
X 1 -X 2 -X 3 represents the group CH=CH-CH=CH, S-CH=CH or CH=CH-S;
Y represents a single bond, CH 2 , O, S, CH 2 O, OCH 2 , CH 2 S, SCH 2 , CH 2 CH 2 or CH=CH; and
Z 1 -Z 2 represents the group C=CH, CH-CH 2 , CH-CH(COOH)- or N- (CH 2 ) n - (wherein n is an integer of 1 to 3).摘要翻译: 公开了可用作AII受体拮抗剂的新型三环化合物和盐。 这些是式I化合物及其盐:
R 1代表氢原子,卤素或C 1 -C 6烷基; A代表氰基,羧基,四唑基,氰基取代的苯基,羧基取代的苯基或四唑基取代的苯基; V表示 - (CH 2)m - ,其中m为0,1或2; W代表式为α,β,γ或δ的基团,其中α为:其中R 2,R 3和R 4各自为氢,卤素,C 1 -C 6烷基,C 3 -C 6环烷基,卤代C 1 -C 6烷基,羟基 ,C 1 -C 6烷氧基,氨基,C 1 -C 6烷基氨基,羧基或C 1 -C 6烷氧基羰基; 且Q 1 -Q 2 -Q 3 -Q 4表示N = CH-CH = CH,CH = CH-CH = CH或CH 2 -CH 2 -CH 2 -CH 2:β为:CHEM 其中R 2,R 3和R 4如上所定义:γ是:CHEM,其中R 5和R 6各自代表氢,C 1 -C 6烷基或C 3 -C 6环烷基 R 7表示羧基,C 1 -C 6烷氧基羰基,氨基甲酰基或羟甲基; 并且δ是:其中R 8和R 9各自表示氢或C 1 -C 6烷基,Q表示N或CH; X 1 -X 2 -X 3表示CH = CH-CH = CH,S-CH = CH或CH = CH-S; Y表示单键,CH2,O,S,CH2O,OCH2,CH2S,SCH2,CH2CH2或CH = CH; Z 1 -Z 2表示基团C = CH,CH-CH 2,CH-CH(COOH) - 或N-(CH 2)n - (其中n为1〜3的整数)。 -
公开(公告)号:EP0549352B1
公开(公告)日:2000-03-01
申请号:EP92311777.4
申请日:1992-12-24
发明人: Ohshima, Etsuo , Kanai, Fumihiko , Sato, Hideyuki , Obase, Hiroyuki , Kumazawa, Toshiaki , Takahara, Shiho , Ohno, Tetsuji , Ishikawa, Tomoko , Yamada, Koji
IPC分类号: C07D471/04 , A61K31/435 , A61K31/41 , A61K31/55 , A61K31/54 , C07D405/06 , C07D519/00 , C07D405/14 , C07D403/14 , C07D403/06 , C07D401/12
CPC分类号: C07D249/08 , C07D231/12 , C07D233/56 , C07D403/06 , C07D403/12 , C07D403/14 , C07D405/06 , C07D471/04
-
公开(公告)号:EP0549352A3
公开(公告)日:1993-07-28
申请号:EP92311777.4
申请日:1992-12-24
发明人: Ohshima, Etsuo , Kanai, Fumihiko , Sato, Hideyuki , Obase, Hiroyuki , Kumazawa, Toshiaki , Takahara, Shiho , Ohno, Tetsuji , Ishikawa, Tomoko , Yamada, Koji
IPC分类号: C07D471/04 , A61K31/435 , A61K31/41 , A61K31/55 , A61K31/54 , C07D405/06 , C07D519/00 , C07D405/14 , C07D403/14 , C07D403/06 , C07D401/12
CPC分类号: C07D249/08 , C07D231/12 , C07D233/56 , C07D403/06 , C07D403/12 , C07D403/14 , C07D405/06 , C07D471/04
摘要: Novel tricyclic compounds and salts are disclosed useful as AII receptor antagonists. These are compounds of the formula I and their salts:
R1 represents hudrogen, halogen or C 1 -C 6 alkyl;
A represents cyano, carboxyl, tetrazolyl, cyano-substituted phenyl, carboxyl-substituted phenyl or tetrazolyl-substituted phenyl;
V represents -(CH 2 ) m -, where m is 0,1 or 2;
W represents a group of the formula α, β, γ or δ
where α is:
where R 2 , R 3 and R 4 are each hydrogen, halogen, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, halogenated C 1 -C 6 alkyl, hydroxy, C 1 -C 6 alkoxy, amino, C 1 -C 6 alkylamino, carboxyl or C 1 -C 6 alkoxycarbonyl; and Q 1 -Q 2 -Q 3 -Q 4 represents N=CH-CH=CH, CH=CH-CH=CH or CH 2 -CH 2 -CH 2 -CH 2 :
β is:
wherein R 2 , R 3 and R 4 are as defined above:
γ is:
where R 5 and R 6 each represent hydrogen, C 1 -C 6 alkyl or C 3 -C 6 cycloalkyl, and R 7 represents carboxyl, C 1 -C 6 alkoxycarbonyl, carbamoyl or hydroxymethyl; and
δ is:
where R 8 and R 9 each represent hydrogen or C 1 -C 6 alkyl, and Q represents N or CH;
X 1 -X 2 -X 3 represents the group CH=CH-CH=CH, S-CH=CH or CH=CH-S;
Y represents a single bond, CH 2 , O, S, CH 2 O, OCH 2 , CH 2 S, SCH 2 , CH 2 CH 2 or CH=CH; and
Z 1 -Z 2 represents the group C=CH, CH-CH 2 , CH-CH(COOH)- or N- (CH 2 ) n - (wherein n is an integer of 1 to 3).-
公开(公告)号:EP1688418B1
公开(公告)日:2017-03-15
申请号:EP06004401.3
申请日:2002-11-13
发明人: Luly, Jay R. , Nakasato, Yoshisuke , Ohshima, Etsuo , Harriman, Geraldine C. B. , Carson, Kenneth G. , Ghosh, Shomir , Elder, Amy M. , Mattia, Karen M.
IPC分类号: C07D491/04 , C07D497/04 , C07D223/20 , C07D313/12 , C07D337/12 , A61P1/00 , A61K31/4353 , A61K31/55 , C07D313/00 , C07D221/00 , C07D471/04 , C07D223/00 , C07D519/00 , C07D491/00 , C07D513/04 , C07D337/00 , C07D451/00
CPC分类号: C07D491/04 , C07D211/46
-
-
-
-
-